Angioimmunoblastic T-cell lymphoma associated with immune checkpoint inhibitor treatment
Main Authors: | Taylor C. Duke, MD, Ranjit Nair, MD, Carlos Torres-Cabala, MD, Rodabe N. Amaria, MD, Elizabeth Keiser, MD, Roberto Miranda, MD, Swaminathan P. Iyer, MD, Meghan Heberton, MD |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-12-01
|
Series: | JAAD Case Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352512620306986 |
Similar Items
-
Cutaneous involvement in angioimmunoblastic T-cell lymphoma
by: Papadavid Evangelia, et al.
Published: (2010-01-01) -
Kawasaki disease as the presenting featare of angioimmunoblastic lymphoma
by: S.Alle Yasin, et al.
Published: (2005-01-01) -
Angioimmunoblastic T-Cell lymphoma: A critical analysis of clinical, morphologic and immunophenotypic features
by: Bal Munita, et al.
Published: (2010-10-01) -
Hypercalcemia as a rare presentation of angioimmunoblastic T cell lymphoma: a case report
by: Sana Chams, et al.
Published: (2018-04-01) -
Angioimmunoblastic T-Cell Lymphoma: A Diagnostic Challenge
by: Jorge Ocampo-Garza, et al.
Published: (2014-12-01)